Lantz Financial’s Thermo Fisher Scientific TMO Stock Holding History

Lantz Financial’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-375	Closed	-$217K	–	254
2025 Q4	$217K	Buy	+375	New	+$212K	0.05%	238
2025 Q2	–	Sell	-597	Closed	-$297K	–	241
2025 Q1	$297K	Buy	597 +4	+0.7%	+$2.17K	0.08%	177
2024 Q4	$308K	Buy	593 +3	+0.5%	+$1.65K	0.08%	176
2024 Q3	$365K	Buy	590 +28	+5%	+$16.6K	0.1%	163
2024 Q2	$311K	Sell	562 -9	-2%	-$5.16K	0.1%	166
2024 Q1	$332K	Buy	571 +87	+18%	+$48.8K	0.11%	152
2023 Q4	$257K	Buy	484 +73	+18%	+$35.3K	0.09%	174
2023 Q3	$208K	Buy	411 +8	+2%	+$4.26K	0.08%	173
2023 Q2	$210K	Buy	403 +2	+0.5%	+$1.08K	0.08%	180
2023 Q1	$231K	Hold	401	–	–	0.1%	169
2022 Q4	$221K	Buy	+401	New	+$212K	0.1%	165

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lantz Financial's TMO Position: Q1 2026 in Review

Lantz Financial sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 375 shares — an estimated $217K sold.

Lantz Financial first reported a position in TMO in Q4 2022 and held it in 11 quarters. The position peaked at $365K in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Lantz Financial reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Lantz Financial sold 375 Thermo Fisher Scientific shares in Q1 2026, an estimated $217K.
Lantz Financial first reported a position in Thermo Fisher Scientific in Q4 2022 and held it in 11 quarters.
Lantz Financial's Thermo Fisher Scientific position peaked at $365K in Q3 2024.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Lantz Financial's 13F filing for Q1 2026, filed 9 Apr 2026.